Ambareesh Baliga, Independent Market Expert told CNBC-TV18, "I had a call on Shasun Pharmaceuticals quite some time back which is getting merged. I had a call on that at about Rs 65 levels. I had a call on Dishman Pharmaceuticals & Chemicals at about Rs 40 levels. "At the current juncture I would still prefer the largecap pharmaceutical stocks which have corrected - stocks like Lupin, Sun Pharmaceutical Industries should be there in your portfolio," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
